Merck
Search Within

657-27-2

Applied Filters:
Keyword:'657-27-2'
Showing 1-4 of 4 results for "657-27-2" within Papers
John R B Perry et al.
Human molecular genetics, 19(3), 535-544 (2009-11-26)
Epidemiological studies consistently show that circulating sex hormone binding globulin (SHBG) levels are lower in type 2 diabetes patients than non-diabetic individuals, but the causal nature of this association is controversial. Genetic studies can help dissect causal directions of epidemiological
Edward Malone et al.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 26(5), 672-682 (2009-08-15)
A confirmatory method has been developed and validated that allows for the simultaneous detection of medroxyprogesterone acetate (MPA), megestrol acetate (MGA), melengestrol acetate (MLA), chlormadinone acetate (CMA) and delmadinone acetate (DMA) in animal kidney fat using liquid chromatography-tandem mass spectrometry
Markku Miettinen et al.
The American journal of surgical pathology, 35(3), 432-441 (2011-02-15)
ERG, an ETS family transcription factor, is known to be expressed in endothelial cells, and oncogenic ERG gene fusions occur in subsets of prostatic carcinoma, acute myeloid leukemia, and Ewing sarcoma. In this study, we immunohistochemically investigated nuclear ERG expression
Alper Kirkpantur et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26(4), 1346-1354 (2010-09-04)
Fibroblast growth factor-23 (FGF-23) is a phosphorus-regulating substance. Circulating FGF-23 levels increase markedly in dialysis patients and are independently associated with increased risk of mortality. Given the fact that cardiovascular disease is the leading cause of death in dialysis patients
Page 1 of 1
Page 1 of 1